Skip to Main Content

How much is one month of advice from Michael Pearson worth? Valeant Pharmaceuticals is willing to pay more than $83,000.

Valeant stock may have tanked and its growth strategy imploded during his final months running the beleaguered drug maker, but Pearson was just awarded a consulting contract that will pay him more than $583,000 through the end of this year and as much as $180,000 next year, or $15,000 a month, according to a filing with the US Securities and Exchange Commission. The fees will be pro-rated for partial months.


The consulting services were listed in a letter that outlines his separation agreement, which was dated May 26, more than three weeks after his tenure as Valeant chief executive ended. He has since been replaced by former Perrigo Chief Executive Joe Papa.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.